Pfizer plans to apply for approval of its RSV vaccine by year’s end, in hopes a vaccine could be available before next year’s respiratory-illness season.
Pfizer’s RSV vaccine, given during pregnancy, protects infants from severe illness
Pfizer plans to apply for approval of its RSV vaccine by year’s end, in hopes a vaccine could be available before next year’s respiratory-illness season.